Marijuana-Based Clinical Research Ready to Skyrocket as Feds Loosen Up

Aug 27, 2019 | Cannabis, Cannabis Research, DEA

Marijuana-Based Clinical Research Ready to Skyrocket as Feds Loosen Up

Cannabis-based clinical research will soon explode in the U.S. as the federal government is preparing to downgrade marijuana’s Controlled Substances Act classification, meaning they will allow for major expansions of cannabis -based research.

Why are they doing this?

Probably in part to a wave of change throughout the country as to the legal status of marijuana. More specifically, a major lawsuit by Dr. Sue Sisley of the Scottsdale Research Institute sought to end three years of stalling by the Drug Enforcement agency. What was Dr. Sisley challenging? For half a century, only one grow was legally approved for such purposes, reports Think Progress. That institution—a University of Mississippi facility contracted by the National Institute on Drug Abuse (NIDA).

What Happened Monday?

In a regulatory filing, Attorney General William Barr made warm remarks that included a press release essentially establishing a Dr. Sisley victory.

Moving Forward

The DEA will soon unveil proposed regulatory framework to govern applications to grow cannabis for scientific and medical research.

0 Comments

Pin It on Pinterest